Pure Global

Syphilis Rapid Test Device - India CDSCO Medical Device Registration

Syphilis Rapid Test Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000016_cc818e77460000fdff28a61dae026422_9af212493e2ba36ebe25201f43707490. This device is marketed under the brand name First View. The license holder is BIOLINE DIAGNOSTICS LLP, and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Syphilis Rapid Test Device
UID: MFG/IVD/2020/000016_cc818e77460000fdff28a61dae026422_9af212493e2ba36ebe25201f43707490

Brand Name

First View

Device Class

Class D

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

First View Syphilis is a rapid self-performing, qualitative determination of Syphilis in human blood as an aid for in vitro diagnosis

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing